Cargando...
Terlipressin versus other vasoactive drugs for hepatorenal syndrome
BACKGROUND: Hepatorenal syndrome is defined as severe renal failure occurring in people with cirrhosis and ascites. Systematic reviews of randomised clinical trials found that, compared with placebo, terlipressin may reduce mortality and improve renal function in people with hepatorenal syndrome, bu...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2017
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483765/ https://ncbi.nlm.nih.gov/pubmed/28953318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011532.pub2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|